Bristol-Myers Spokesperson Says Grade 5 Event That Was Disclosed As Part Of Data Disclosure At MS Toronto Occurred After Trial Pause; Working Closely With FDA To Restart Trial As Soon As Possible, With The Goal Of Resuming Enrollment In Early 2027;...
